Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
At the European Hematology Association (EHA) 2022 Congress in Vienna, Austria, new clinical trial data were reported for numerous hematologic malignancies. In this module, Alessandra Tedeschi, MD; Stéphane de Botton, MD; and Jesús F. San-Miguel, MD, PhD, review and discuss the clinical implications of key studies in acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), multiple myeloma, myelodysplastic syndromes (MDS), and Waldenström macroglobulinemia.
The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slideset, which can be found here or downloaded by clicking any of the slide thumbnails alongside the expert commentary.
Clinical Care Options plans to measure the educational impact of this activity. A few questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.
Before continuing with this educational activity, please take a moment to answer the following questions.